A prospective validation study. M. Ramaswamy as an author. Read Article Category: NewsBy Murali RamaswamyJuly 30, 2019Post navigationPreviousPrevious post:A Phase 1b Study of Vismodegib with Pirfenidone in Patients with Idiopathic Pulmonary FibrosisNextNext post:Your Well-Being: Pulmonary FibrosisRelated PostsPhase 3 Trials of Inhaled Treprostinil for Idiopathic Pulmonary FibrosisMay 21, 2026Screening for Pulmonary Hypertension in Interstitial Lung Disease: Preliminary Results from the PHINDER StudyMay 21, 2026PULMONIX VOLUNTEERS WITH THE KELLIN FOUNDATION TO SUPPORT FAMILIES IN NEEDJuly 18, 2025PULMONIX NAMED FINALIST FOR TRIAD BUSINESS JOURNAL’S BEST PLACES TO WORKMay 29, 2025
Screening for Pulmonary Hypertension in Interstitial Lung Disease: Preliminary Results from the PHINDER StudyMay 21, 2026
